• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前甲状腺球蛋白测量在甲状腺癌复发风险和治疗反应中的应用。

Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.

机构信息

Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado School of Medicine, 12631 E 17th Ave., C-313 Mail Stop, Aurora, CO, 80045, United States.

Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, 12801 E. 17th Ave., 7103, Research 1 South, Aurora, CO, 80045, United States; Department of Biomedical Informatics, University of Colorado School of Medicine, 1890 N. Revere Court, Mailstop F600, Aurora, CO, 80045, United States.

出版信息

Am J Surg. 2024 Dec;238:115818. doi: 10.1016/j.amjsurg.2024.115818. Epub 2024 Jul 3.

DOI:10.1016/j.amjsurg.2024.115818
PMID:39004566
Abstract

BACKGROUND

Thyroid cancer has an overall favorable prognosis, but no pre-operative biochemical marker has been shown to distinguish between low and high-risk disease or predict response to therapy.

METHODS

We retrospectively reviewed 162 patients that underwent thyroid surgery for thyroid cancer between 2006 and 2022 in whom a pre-operative thyroglobulin level (Tg) was measured. We subdivided patients into low, intermediate and high-risk thyroid cancer and based on their response to therapy per ATA guidelines.

RESULTS

We showed that as pre-operative Tg level increased, patients were more likely to have high-risk disease (p ​< ​0.01). We found a linear association between the primary tumor size and high-risk histology with pre-operative Tg (p ​< ​0.01). Pre-operative Tg level was significantly associated with response to therapy following initial surgical management. Specifically, as pre-operative Tg increases, patients were less likely to achieve an excellent response (p ​< ​0.01).

CONCLUSIONS

Our retrospective analysis demonstrated that pre-operative Tg is significantly associated with ATA structural risk of recurrence and response to therapy and may have the potential to guide initial therapy and follow-up management.

摘要

背景

甲状腺癌总体预后良好,但尚无术前生化标志物可区分低危和高危疾病,或预测对治疗的反应。

方法

我们回顾性分析了 2006 年至 2022 年间因甲状腺癌接受甲状腺手术的 162 例患者,这些患者在术前测量了甲状腺球蛋白(Tg)水平。我们将患者分为低危、中危和高危甲状腺癌,并根据 ATA 指南中对治疗的反应进行了分类。

结果

我们发现,随着术前 Tg 水平的升高,患者更有可能患有高危疾病(p < 0.01)。我们发现术前 Tg 与原发肿瘤大小和高危组织学之间存在线性关联(p < 0.01)。术前 Tg 水平与初始手术治疗后的治疗反应显著相关。具体而言,随着术前 Tg 的升高,患者不太可能获得优异的反应(p < 0.01)。

结论

我们的回顾性分析表明,术前 Tg 与 ATA 复发结构风险和对治疗的反应显著相关,可能有潜力指导初始治疗和随访管理。

相似文献

1
Pre-operative thyroglobulin measurement for thyroid cancer risk of recurrence and response to therapy.术前甲状腺球蛋白测量在甲状腺癌复发风险和治疗反应中的应用。
Am J Surg. 2024 Dec;238:115818. doi: 10.1016/j.amjsurg.2024.115818. Epub 2024 Jul 3.
2
Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.1611 例甲状腺乳头状癌患者全甲状腺切除术后复发的预测因素:术后刺激血清甲状腺球蛋白和 ATA 初始及动态风险评估。
Arch Endocrinol Metab. 2024 Apr 4;68:e220506. doi: 10.20945/2359-4292-2022-0506.
3
Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?在首次疾病评估前,消融治疗前刺激甲状腺球蛋白 <1ng/mL 的中高危甲状腺乳头状癌患者是否仍需要 TSH 抑制治疗?
Endocrine. 2019 Jul;65(1):149-154. doi: 10.1007/s12020-019-01914-z. Epub 2019 Mar 28.
4
Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.血清甲状腺球蛋白对甲状腺癌患者行甲状腺叶切除术结构复发的预测价值。
Thyroid. 2021 Sep;31(9):1391-1399. doi: 10.1089/thy.2021.0209. Epub 2021 Aug 25.
5
Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.术前甲状腺切除术患者中明显升高的甲状腺球蛋白水平与转移负担相关。
J Surg Res. 2014 Mar;187(1):1-5. doi: 10.1016/j.jss.2013.12.017. Epub 2013 Dec 18.
6
Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.分化型甲状腺癌131I消融治疗时术后刺激甲状腺球蛋白水平的重要性。
Asian Pac J Cancer Prev. 2014;15(6):2523-7. doi: 10.7314/apjcp.2014.15.6.2523.
7
Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.根据美国甲状腺协会(ATA)标准,具有中等复发风险的甲状腺乳头状癌患者,如果术后甲状腺球蛋白水平较低,可以重新分类为低风险。
Thyroid. 2015 Nov;25(11):1243-8. doi: 10.1089/thy.2015.0294. Epub 2015 Sep 14.
8
Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.甲状腺癌 lobectomy 术后复发的检测:甲状腺球蛋白和甲状腺球蛋白抗体的作用。
J Clin Endocrinol Metab. 2020 Jun 1;105(6). doi: 10.1210/clinem/dgaa152.
9
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary.颈部超声检查和甲状腺球蛋白抑制对识别接受甲状腺全切除术和放射性碘消融治疗的低风险甲状腺癌患者的复发/持续性疾病具有高敏感性,使得刺激甲状腺球蛋白检测不再必要。
J Ultrasound Med. 2017 Nov;36(11):2299-2307. doi: 10.1002/jum.14260. Epub 2017 May 24.
10
Biochemical persistence in thyroid cancer: is there anything to worry about?甲状腺癌中的生化持续性:有什么需要担心的吗?
Endocrine. 2014 Aug;46(3):532-7. doi: 10.1007/s12020-013-0097-6. Epub 2013 Nov 28.

引用本文的文献

1
Comparative analysis of three thyroglobulin immunoassays: analytical performance and clinical implications.三种甲状腺球蛋白免疫测定法的比较分析:分析性能及临床意义
Thyroid Res. 2025 Sep 9;18(1):44. doi: 10.1186/s13044-025-00261-8.